Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies

MLA

Stein-Erik Gullaksen, et al. “Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies.” Cancers, vol. 14, no. 13, May 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....370d9e2c8eae1d7ce67aa795efa8ba32&authtype=sso&custid=ns315887.

APA

Stein-Erik Gullaksen, Geir Bredholt, Emmet Mc Cormack, Ben Davidson, Katrin Kleinmanns, Line Bjorge, Sindre Grindheim, & Cecilie Fredvik Torkildsen. (2022). Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies. Cancers, 14(13).

Chicago

Stein-Erik Gullaksen, Geir Bredholt, Emmet Mc Cormack, Ben Davidson, Katrin Kleinmanns, Line Bjorge, Sindre Grindheim, and Cecilie Fredvik Torkildsen. 2022. “Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies.” Cancers 14 (13). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....370d9e2c8eae1d7ce67aa795efa8ba32&authtype=sso&custid=ns315887.